Risk of acquired drug resistance during DOTS tuberculosis treatment in a setting of high drug resistance Helen S. Cox 1,3, Stefan Niemann 2, Gabit Ismailov.
14 th Meeting of the Core Group of the TB/HIV Working Group Addis Ababa, Ethiopia November 12, 2008 MDR and XDR-TB in the context of HIV: What next? Paul.
